1 / 27

Genetic Analysis in Human Disease

Genetic Analysis in Human Disease. Power of Genetic Analysis. Success stories Age-related Macular Degeneration Crohn’s Disease Allopecia Areata Type1 Diabetes Not so successful Ovarian Cancer Obesity. Getting Started Question to be answered.

clem
Download Presentation

Genetic Analysis in Human Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Genetic Analysis in Human Disease

  2. Power of Genetic Analysis • Success stories • Age-related Macular Degeneration • Crohn’s Disease • AllopeciaAreata • Type1 Diabetes • Not so successful • Ovarian Cancer • Obesity

  3. Getting StartedQuestion to be answered Which gene(s) are responsible for genetic susceptibility for Disease A? • What is the measurable difference • Clinical phenotype • biomarkers, drug response, outcome • Who is affected • Demographics • male/female, ethnic/racial background, age

  4. Study Design • Linkage (single gene diseases: cystic fibrosis, Huntington’s disease, Duchene's Muscular Dystrophy) • Families • Association (complex diseases: RA, SLE, breast cancer, autism, allopecia, AMD, Alzheimer’s) • Case - control

  5. Linkage vs. Association Analysis 5M

  6. Linkage Studies- all in the family Family based method to map location of disease causing loci • Families • Multiplex • Trios • Sib pairs

  7. Staged Genetic Analysis - RALinkage/Association/Candidate Gene

  8. Association Studies – numbers game • Genome-Wide Association Studies (GWAS) • Tests the whole genome for a statistical association between a marker and a trait in unrelated cases and controls Controls Affecteds

  9. Staged Genetic Analysis - RALinkage/Association/Candidate Gene

  10. -7 So you have a hit: p< 5 x10 • Validation/ replication • Dense mapping/Sequencing • Functional Analysis

  11. Validation • Independent replication set • Same inclusion/exclusion subject criteria • Sample size • Genotyping platform • Same polymorphism • Analysis • Different ethnic group (added bonus)

  12. Staged Genetic Analysis - RALinkage/Association/Candidate Gene

  13. Dense Mapping/Sequencing • Identifies the boundaries of your signal • close in on the target gene/ causal variant • find other (common or rare) variants

  14. Functional Analysis • Does your gene make sense? • pathway • function • cell type • expression • animal models PTPN22: first non-MHC gene associated with RA (TCR signaling)

  15. Perfect vs Imperfect Worlds • Perfect world • Linkage and/or GWAS – identify causative gene polymorphism for your disease Publish • Imperfect world • nothing significant • identify genes that have no apparent influence in your disease of interest • Now what?

  16. What Happened? • Disease has no genetic component. • Viral, bacterial, environmental • Genetic effect is small and your sample size wasn’t big enough to detect it. • CDCV vs CDRV • Phenotype /or demographics too heterogeneous • Too many outliers • Wrong controls. • Population stratification; admixture • Not asking the right question. • wrong statistics, wrong model

  17. Meta-Analysis – Bigger is better • Meta-analysis - combines genetic data from multiple studies; allows identification of new loci • Rheumatoid Arthritis • Lupus • Crohn’s disease • Alzheimer’s • Schizophrenia • Autism

  18. Influence of Admixture • Not all Subjects are the same

  19. Missing heritability • Except for a few diseases (AMD, T1D) genetics explains less than 50% of risk. • Large number of genes with small effects • Other influences?

  20. Other Contributors Any change in gene expression can influence disease state- not always related directly to DNA sequence • Environmental • Epigenetic • MicroRNA • Microbiome • Copy Number Variation • Gene-Gene Interactions • Alternative splice sites/transcription start sites

  21. GWAS- What have we found? 3,800 SNPs identified for 427 diseases and traits

  22. Genome-Wide Association Studies • The promise • Better understanding of biological processes leading to disease pathogenesis • Development of new treatments • Identify non-genetic influences of disease • Better predictive models of risk • and the reality • Few causal variants have been identified • Clinical heterogeneity and complexity of disease • Genetic results don’t account for all of disease risk

  23. Pathway Analysis – Crohn’s disease

  24. Personalized Medicine "5P" Health Care Personalized medicine is: • Predictive: Uses state-of-the-art molecular and diagnostic tools to precisely predict individual health risks and outcomes • Personalized: Is informed by each person’s unique clinical, social, genetic, genomic, and environmental profile • Preventive: Emphasizes wellness and prevention to stop disease before it progresses • Preemptive: Incorporates action-oriented, individualized health planning • Participatory: Empowers each patient to participate in their own care, with coordinated support from their health care team http://www.dukepersonalizedmedicine.org/what_is_personalized_medicine

  25. Things to remember • You can never have too many samples • You can never collect too much information on a subject • The more you know about the disease and your subjects, the more homogeneous your study will be and the less interference from “population” noise you will have.

  26. Questions • True/ False • Association studies are comprised of many multiplex families • With 100 randomly chosen polymorphisms and 10,000 diverse human subjects you have a high probability of finding the causative polymorphism for your disease of interest • It’s better to ascertain all of your case subjects in one small town and all of your control subjects in a distant small town so there is no overlap in genetic composition. • The ability to combine data from different large studies to perform a meta-analysis can result in identifying new loci which were not significant in the original studies • If it weren’t for admixture we would not be able to study complex genetics.

More Related